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then incorporated into mixed reality systems 
consisting of cameras, a display, and several sen‑
sors. These systems enable physicians to interact 
with the mixed reality 3D images in real ‑time. 
The camera tracks the user’s movements in re‑
lation to virtual objects, whilst a head ‑mounted 
display allows users to observe these virtual ob‑
jects in the physical world. The potential utility 
of MR imaging can be enhanced by combining 
advanced imagining with artificial intelligence 
technologies. In the future, a key advantage of 
current artificial intelligence technologies is that 
they can significantly shorten the time required 
to create, process and subsequently display com‑
plex MR images compared with conventional 3D 
reconstructions from echocardiography, CT, or 
MRI imaging. This faster processing can be har‑
nessed to provide an enhanced visualization and 
quantitative feedback in real ‑time to guide pre‑
procedural planning as well as to monitor com‑
plex interventions intraprocedurally.
Using mixed reality imaging for preprocedural plan‑
ning and intraprocedural monitoring Mixed reali‑
ty imaging is versatile and can be adapted accord‑
ing to the underlying anatomy and intervention 
being performed. The ability to overlay computer‑
‑generated 3D models on top of patient ‑specific 
imaging can enable physicians to understand 
the often ‑complex geometric interactions between 
anatomy and intended device. This can provide 
a more complete understanding of both the po‑
tential impact of the intervention as well as assist‑
ing in selection of the device and procedural tech‑
nique (Supplementary materials, Figure S1A–S1E).
Introduction Interventional cardiology is 
a rapidly evolving field, fueled by the techno‑
logical development in devices and procedures. 
Advancements in imaging technologies have 
played a key role in facilitating the planning 
and monitoring of complex coronary, structur‑
al, and peripheral interventions. However, as 
the complexity of interventions increases, there 
is a need now for new imaging solutions to an‑
swer emerging clinical problems.
Mixed reality (MR) imaging is an emerging 
advanced imaging technique, whereby virtual 
computer ‑generated 3‑dimensional (3D) mod‑
els are added onto patient ‑specific images ac‑
quired from either echocardiography, computed 
tomography (CT) or magnetic resonance imag‑
ing (MRI). Mixed reality imaging can offer new 
solutions to complex interventional problems.
The aim of this report is to describe novel 3D 
imaging techniques with mixed reality enhance‑
ment and to demonstrate how these can be used 
to facilitate and optimize preprocedural plan‑
ning and intraprocedural monitoring of coro‑
nary and structural interventions. 
Technologies for creating 3D models and sim‑
ulations are invaluable in planning and moni‑
toring treatments. Mixed reality is character‑
ized by great versatility, allowing views from 
different perspectives, depending on the phy‑
sician’s needs.
Methods Mixed reality imaging Mixed reality 
imaging combines imaging data acquired from 
patients with computer ‑generated images to cre‑
ate 3D holographic images. These 3D images are 
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 Figure 1 Flow chart demonstrating how emerging advanced imaging technologies can be integrated alongside contemporary imaging techniques for 
preprocedural planning and intraprocedural monitoring of percutaneous coronary interventions (A) and percutaneous structural interventions (B)
 Abbreviations: CT, computed tomography; FFR, fractional flow reserve; IVUS, intravascular ultrasound; MRI, magnetic resonance imaging; 
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NIRS, near ‑infrared spectroscopy; SPECT, single ‑photon emission computed tomography; OCT, optical coherence tomography; PET, positron emission tomography; 
QCA, quantitative coronary analysis; TAVI, transcatheter aortic valve implantation; 3D, 3-dimensional; 2D, 2-dimensional
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tomography [CT], CT perfusion, positron emis‑
sion tomography, FFR ‑based CT, magnetic res‑
onance imaging [MRI], single ‑photon emission 
computed tomography).5 Based on the resulting 
images, 3D modelling techniques can be used 
to create and analyze patient ‑specific models, 
which may aid the decision ‑making process, es‑
pecially when trying to determine the best meth‑
od of revascularization.
The potential advantages of these methods 
in the planning for patients with CAD are rel‑
atively limited. Currently, FFR is recommend‑
ed for the assessment of intermediate coro‑
nary stenosis. An emerging alternative is CT‑
‑FFR which uses high ‑quality images from car‑
diac CT scans to create an arterial 3D model to 
simulate the blood flow. The resulting software 
can determine the presence and functional sig‑
nificance of a coronary stenosis without an in‑
vasive procedure.
Patients referred for percutaneous coronary 
interventions (PCI) can undergo real ‑time im‑
aging during the procedure. In all cases, imaging 
is performed with 2D angiography, with intra‑
‑coronary imaging (IVUS, IVUS ‑NIRS, OCT) uti‑
lized at the operator’s discretion. An emerging 
concept is the use of 3D angiography to guide 
complex interventions and 3D reconstructions 
of IVUS, IVUS ‑NIRS, or OCT images to evalu‑
ate plaque morphology, vessel remodeling, and 
stent geometry of implemented stents.6
Structural interventions can be more com‑
plex and can require more detailed preproce‑
dural imaging to better understand the anato‑
my, pathology, and surrounding cardiac struc‑
tures that might be involved during the in‑
tervention. Conventionally, preprocedur‑
al planning involves baseline transthoracic 
echocardiography which is then supplement‑
ed by additional diagnostic imaging consist‑
ing of either transesophageal echocardiogra‑
phy, CT, or MRI methods alone or in combina‑
tion. Various quantitative and qualitative pa‑
rameters are then derived from these differ‑
ent imaging modalities.
A further evolution in CT and MRI imaging 
platforms involves segmentation of selected 
cardiac structures, which can be performed ei‑
ther manually or semi‑ or fully ‑automatically. 
Further modelling and analysis of these seg‑
mentations can then create 3D graphics, which 
can be visualized or exported onto 3D print‑
ing platforms and / or incorporated into MR 
imaging systems (FIgUre 1A). This innovative ap‑
proach to interpret medical data offers new 
opportunities to both evaluate the underly‑
ing anatomy and plan and simulate subse‑
quent procedures.7
Patients undergoing structural heart inter‑
ventions are usually monitored with transesoph‑
ageal ultrasound in a hybrid operating room. 
The acquired 2D and / or 3D images can then 
Intraprocedurally, the 3D reconstructed 
images derived from either real ‑time stan‑
dard / rotational angiography, or echocardiog‑
raphy, or preprocedural CT or MRI scans can be 
visualized and projected directly onto the oper‑
ators’ field of vision. Furthermore, these imag‑
es can be manipulated and analyzed indepen‑
dently by the interventionist, which provides 
an additional and more flexible source of im‑
aging guidance during complex coronary or 
structural interventions.1 Specific image visu‑
alization in a 3D‑simulated environment pro‑
vides the operator with better depth percep‑
tion, whilst providing additional volumetric 
measurements and data.2
At present, mixed reality imaging is an emerg‑
ing technology, with limited experience and is 
still the subject of ongoing research. Mixed re‑
ality technologies are being introduced into pre‑
procedural planning or intraprocedural moni‑
toring protocols.
Novel imaging ‑based methods to plan and monitor 
coronary and structural interventions Currently, 
imaging technologies are utilized for the diag‑
nosis, classification and preprocedural planning 
of subsequent percutaneous and surgical inter‑
ventions. Imaging technologies also play a vital 
role in the intraprocedural monitoring of inter‑
ventions, and can lead to improvements in pro‑
cedural success and safety whilst potentially im‑
proving procedural time and cost. Mixed reality 
imaging is one example of many other emerg‑
ing advanced imaging technologies.3 The specific 
attributes of each technology vary considerably 
with certain technologies being more advanta‑
geous in specific clinical settings. With the in‑
creasing number of available options, it is im‑
portant to select the right imaging technique 
for the right patient at the right time.
Therefore, we propose a novel imaging ap‑
proach to procedural planning and monitor‑
ing, combining advanced imaging technologies 
such as mixed reality, 3D segmentation, and 
3D printing to improve the planning and per‑
formance of coronary and structural interven‑
tions (FIgUre 1A and 1B).
Statistical analysis No statistical analysis was 
performed. Novel imaging ‑based methods to 
plan and monitor coronary and structural in‑
terventions were proposed as a new concept.
Results and discussion Diagnostic imaging 
used during treatment planning in patients with 
coronary artery disease (CAD) can be divided 
into invasive (angiography, fractional flow re‑
serve [FFR], FFR ‑based quantitative coronary 
analysis, intravascular ultrasound [IVUS], IVUS 
with near ‑infrared spectroscopy [NIRS], opti‑
cal coherence tomography [OCT])4 and nonin‑
vasive methods (echocardiography, computed 
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be exported, processed, and analyzed within 
the mixed reality platforms in real time. These 
3D models can then be manipulated at the op‑
erators’ discretion to provide a seamless inter‑
action between imaging and intervention.
Conclusions Technological advancements have 
provided the stimulus to develop mixed reality 
technologies into interventional practice. These 
technologies can support physicians during pre‑
procedural planning, provide real ‑time detailed 
imaging solutions during complex interventions, 
and offer unique high ‑fidelity training opportu‑
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